8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-KCURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported: September 26, 2014)

Innophos Holdings, Inc.(Exact name of Registrant as specified in its their Charter)

Delaware(States or other jurisdictions of incorporation) 001-33124(Commission File Numbers) 20-1380758(IRS Employer Identification Nos.)

259 Prospect Plains RoadCranbury, New Jersey 08512
(Address of Principal Executive Office, including Zip Code)

(609) 495-2495
(Registrant’s Telephone Number, Including Area Code)

Not Applicable(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

        Effective September 26, 2014, the Registrant’s Board of Directors and those of its subsidiaries, Innophos Investments Holdings, Inc. and Innophos, Inc., increased their size from six to seven members and elected James Zallie, 53, as a director.  Mr. Zallie previously had been recommended for election by the Nominating & Corporate Governance Committee of the Board.  Although assignments to the standing committees of the Board will not be finalized until the next meeting of that body, Mr. Zallie is expected to be named to the Audit Committee and the Nominating & Corporate Governance Committee.

        The Registrant issued a press release concerning the election of Mr. Zallie, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K  and to which reference is hereby made.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibit No.	Description
99.1	Registrant’s press release dated September 30, 2014

SIGNATURES

According to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on their behalf by the undersigned, hereunto duly authorized.

INNOPHOS HOLDINGS, INC.

By: /s/ Robert Harrer

Name: Robert Harrer
Title: Vice President and Chief Financial Officer

Dated: September 26, 2014

EX-99.1

FOR IMMEDIATE RELEASE

INNOPHOS HOLDINGS, INC. ELECTS

JAMES ZALLIE TO BOARD OF DIRECTORS

CRANBURY, New Jersey – (September 30, 2014) – Innophos Holdings, Inc. (NASDAQ: IPHS), a leading international producer of performance-critical and nutritional specialty ingredients, today announced the election of James (Jim) Zallie to its Board of Directors.

Mr. Zallie is Executive Vice President Global Specialties and President North America and EMEA forIngredion Incorporated, a global leader in ingredient solutions for food, beverage, brewing, pharmaceutical and other industrial markets, where he is an officer and member of the executive leadership team. Mr. Zallie came to Ingredion in 2010 with the acquisition of National Starch LLC where he held various positions of increasing responsibility since 1997 and served as President and CEO from 2006 to 2010.

“We are very happy to add a director with Jim’s international experience and background in the food ingredient and specialty chemical industries,” said Randy Gress, Chief Executive Officer and Chairman of the Board. “Jim has a demonstrated track record of delivering above-market growth in both emerging and more challenging developed markets. Accordingly, we believe that, with his knowledge and experience as a successful industry leader, he will contribute to our growth strategy in food and nutritional ingredients.”

Mr. Zallie will serve as an independent director. His election increases the Company’s Board to a total of seven directors.

About Innophos Holdings, Inc.

Innophos is a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. Innophos combines more than a century of experience in specialty phosphate manufacturing with a growing capability in a broad range of other specialty ingredients to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide. Innophos is continually developing new and innovative specialty ingredients addressing specific customer applications and supports these high-value products with industry-leading technical service. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Ogden, UT; North Salt Lake, UT; Salt Lake City, UT; Paterson, NJ; Green Pond, SC; Port Maitland, ON (Canada); Taicang (China); Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please visit www.innophos.com. 'IPHS-G'

Contact Information:

Innophos Holdings, Inc.                 FTI Consulting, Inc.

Investor Relations: (609) 366-1299            Bryan Armstrong

investor.relations@innophos.com             312-553-6707